This scholarship page was last updated on 16 November 2021. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Department of Health and Human Services National Institutes of Health
Typ

Research/project funding

Posted on:

Bewerbungsschluss:

Expired

Reference Number

PAR-22-047

The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms.
Categories: Health.

More Information

Visit Website


Typ

Research/Project Funding

Posted on:

Bewerbungsschluss:

Expired

Reference Number

PAR-22-047

USA